Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $215.34M.
ENTERPRISE VALUE (EV)
$215.34M
Pro-Dex, Inc.
Market Cap
$206.06M
Enterprise Value (EV)
$215.34M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pro-Dex, Inc. (PDEX) | $206.06M | $215.34M |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $207.98M | $124.22M |
| Sionna Therapeutics, Inc. (SION)vs › | $209.05M | $153.79M |
| Compugen Ltd. (CGEN)vs › | $211.33M | $204.07M |
| Alector, Inc. (ALEC)vs › | $211.48M | $184.32M |
| Prelude Therapeutics Incorporated (PRLD)vs › | $213.21M | $204.53M |
| Exagen Inc. (XGN)vs › | $198.87M | $199.83M |
| Niagen Bioscience Inc (NAGE)vs › | $213.44M | $149.03M |
| Surrozen, Inc. (SRZN)vs › | $196.62M | $100.90M |
Market Cap
$206.06M
Total Debt
$17.47M
Cash
$8.19M
Enterprise Value
$215.34M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
